HEALTHSTORY 808· JUNE 26, 2026

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

Delphia Therapeutics has appointed David Kerstein as its chief medical officer. Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 807Democratic Senators Push FCC to Freeze Paramount-Warner Bros Discovery Merger on Foreign Ownership Grounds NEXT STORY 809 →Four Ethereum Early Adopters Cash Out 37,602 ETH, Walking Away With $27M After $150M Peak Evaporated

Keep reading

More from the desk.

28HEALTH

Spruce Biosciences taps Adrian Quartel for chief medical officer role

A chief medical officer is the executive who decides how a drug company designs its clinical trials, interprets the data that comes back, and makes the medical case to regulators. Spruce Biosciences has filled that seat, hiring Adrian…

health1 MIN

39HEALTH

Federal health officials open a 30-day window to reconsider how children's vaccine recommendations are categorized

The federal government has taken a formal step toward reconsidering how children's vaccines are recommended in the United States, though no existing recommendations have changed. That step is a request for information

health2 MIN

53HEALTH

FDA clears Ultragenyx gene therapy in a week of back-to-back regulatory action

A gene therapy has received clearance for use in American patients, one of at least two approvals the Food and Drug Administration processed in a short stretch this week. Gene therapy, in p

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk